Top of the page.
Skip the menu to main contents.
Move to main menu.
Skip to main contents.
Main menu starts here.
Skip the main menu to current location in your website.
Current location in your website.
Skip to main contents.
Start main contents.

  • Stock Price

Drug Development Technology

 

Drug development technology is a new fundamental technology which supports Fujifilm's growth. We continue to create and cultivate this technology by integrating proprietary advanced technologies, which takes advantage of our participation in other fields, with pharmacological evaluation, drug synthesis and drug analysis technologies necessary for drug development.

In not only the infectious disease and radiopharmaceuticals areas where Toyama Chemical Co., Ltd. and FUJIFILM RI Pharma Co., Ltd exhibit their strength but also the oncology area where FUJIFILM Drug Discovery Research Laboratories mainly explores new drugs, our group synergy has been strengthened.

Core technologies derived from these fundamental technologies

FTD technology

[Image]FTD technology

Fujifilm's proprietary technology nurtured in the development of photographic film and other products. It involves formulating desired chemicals and delivering them to targeted sites in appropriate quantity and at appropriate times by means of emulsification, dispersion, nanoparticles, nanocapsule formation and porous & multilayer thin films, etc. By utilizing this FTD technology in drug research and development, we strive to create innovative pharmaceutical products.


Analysis technologies for drug development

[Image]Analysis technologies for drug development

We introduce the function analysis and simulation technologies established through creation of various functional materials as well as analysis, evaluation and simulation technologies(*1) at nano, molecular and atomic scale to the drug development field. In doing so, our R&D is supported by the analysis of the drug structure, body distribution and protein-drug interaction.

  • *1 : See "Analysis, Evaluation and Simulation Technologies."

Synthesis technologies for drug development

[Image]Synthesis technologies for drug development

By using the design and synthesis technology(*2), cultivated in creation of various functional materials such as photographic and liquid-crystal materials, we promote R&D in the drug development field. Also, we further utilize and expand our unique library of 200,000 compounds, accumulated through development of various products including photographic films, in the creation of pharmaceutical products.

  • *2 : See "Organic Material Technology."

Pharmacological technologies for drug development

[Image]Pharmacological technologies for drug development

In addition to the capability to employ leading-edge scientific intelligence in the drug development research, pharmacological technologies, such as active compounds design (drug design), pharmacological evaluation by utilizing pharmacokinetic analysis and imaging technologies and pharmacokinetics/safety evaluation, support our R&D in drug development. Fujifilm Group companies such as Toyama Chemical Co., Ltd., FUJIFILM RI Pharma Co., Ltd. and Perseus Proteomics Inc. work together through leverage of their individual strengths.


Related Information

Business Field

Introduction to the extensive business domain of the Fujifilm Group.

Creating Technology Synergies

Synergies generated from unique technological seeds owned by individual group companies.


Sub-menu starts here.

IR Calendar

FAQs

Back to Top
Footer starts here.
Pages ends here.
Move to top of the page.